HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuping Donsante Selected Research
Yuping Donsante Research Topics
Disease
6
Dystonia (Limb Dystonia)
01/2023 - 01/2018
2
Movement Disorders (Movement Disorder)
01/2023 - 08/2021
2
Parkinson Disease (Parkinson's Disease)
01/2023 - 08/2021
2
Dopa-responsive Dystonia
01/2023 - 01/2021
1
Parkinsonian Disorders (Parkinsonism)
01/2023
1
Dystonia musculorum deformans type 1
01/2022
1
Central Nervous System Diseases (CNS Diseases)
08/2021
1
Dystonic Disorders (Writer's Cramp)
01/2021
Drug/Important Bio-Agent (IBA)
5
Dopamine (Intropin)
FDA Link
Generic
01/2023 - 01/2018
2
Dopamine Receptors (Dopamine Receptor)
IBA
01/2023 - 01/2018
2
Dopamine Agonists (Dopamine Agonist)
IBA
01/2023 - 01/2018
2
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
01/2022 - 08/2021
2
Neurotransmitter Agents (Neurotransmitter)
IBA
08/2021 - 01/2021
1
Dopamine Antagonists
IBA
01/2023
1
Raclopride
IBA
01/2023
1
Levodopa (L Dopa)
FDA Link
Generic
01/2023
1
Phosphotransferases (Kinase)
IBA
01/2023
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
01/2023
1
Muscarinic M4 Receptor
IBA
01/2022
1
Trihexyphenidyl (Artane)
FDA Link
Generic
01/2022
1
Cholinergic Agents (Cholinergics)
IBA
01/2022
1
2- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidine
IBA
01/2022
1
Muscarinic Antagonists
IBA
08/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
Dopamine Agents (Dopaminergic Agents)
IBA
01/2018
Therapy/Procedure
2
Therapeutics
01/2022 - 08/2021